Marlborough-based pharmaceutical company TheracosBio appointed Jeff McGroarty as its first full-time chief financial officer. His appointment comes following regulatory approval of a new diabetes drug, TheracosBio’s first commercial product.
BERWYN, Pa., Aug. 29, 2022 /PRNewswire/ Annovis Bio, Inc. , a clinical-stage drug platform company addressing neurodegenerative diseases, announced the appointment of Henry Hagopian III as Chief. | August 29, 2022
Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases,.
(1)
Berwyn, Pennsylvania (Newsfile Corp. - May 11, 2021) - Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer s disease (AD), Parkinson s disease (PD) and other neurodegenerative diseases, today announced that management will participate at the Benzinga Global Small Cap Conference taking place online May 13-14, 2021.
Annovis Bio CEO Maria Maccecchini, Ph.D. will deliver a corporate presentation at 3:10 p.m. ET on May 13, 2021.
Investors can request a one-on-one meeting with Dr. Maccecchini and Annovis Bio CFO Jeff McGroarty using the networking feature within the virtual conference platform.
To register for the conference, visit: https://www.benzinga.com/events/small-cap/global/